Myeloma Test Results, Updated May 9, 2014, Page 1 of 7.

Looks best in a wide browser window. For treatments and some discussion, see Treatment Table. For charts of some values see Charts.

Test	Range Min	Range Max	2013 1212	2014 0109	2014 0206	2014 0306	2014 0403	2014 0501
Serum Lambda FLC mg/dL (neph)	0.57	2.63	2.69	3.64	3.70	3.51	3.26	3.38
Serum Kappa FLC mg/dL (neph)	0.33	1.94	1.32	1.52	1.03	1.29	1.37	1.39
Serum K/L Ratio (neph)	0.26	1.65	0.49	0.42	0.28	0.37	0.42	0.41
Serum IgG mg/dL	750	1550	1150	1280	1260	1300	1270	1340
Serum IgA mg/dL	80	450	39	45	40	53	44	42
Serum IgM mg/dL	45	300	16	17	14	17	16	17
Bone marrow plasma cells %	0.1	1.5
Abnormal cohort in marrow %		0
SPEP Monoclonal Peak g/dL		0	1.1	1.0	0.9	1.1	1.1	1.0
Total protein g/dL	6.3	7.9	7.1	7.0	6.9	7.0	6.9	7.2
Serum B2M mg/L	0.70	1.80
Serum ESR mm/hr	0	20

CBC RBC red blood count M/uL	4.50	5.90	4.54	4.33	4.41	4.17	4.37	4.27
CBC HGB hemoglobin g/dL	13.5	18.0	15.8	14.9	15.3	14.8	15.2	14.8
CBC PLT platelets K/uL	130	430	166	177	170	159	191	169
CBC WBC white blood count K/uL	3.5	10.8	3.7	5.1	4.3	4.4	4.3	3.8
CBC ANC absolute neutrophils K/uL	1.7	7.0	1.43	1.7	3.1	1.9	1.9	1.9
CBC EO# absolute eosinophils K/uL	0	0.35	0.27	0.5	0.0	0.4	0.2	0.2

Chem LDH U/L	122	222	168	145	203	160	155	177
Chem ALT U/L	7.0	55.0	39	34	41	39	36	43
Chem AST U/L	15.0	48.0	33	27	37	33	32	34
Chem Albumin g/dL	3.4	5.0	3.7	3.6	3.4	3.6	3.5	3.5
Chem BUN mg/dL	7.0	18.0
Chem Calcium mg/dL	8.9	10.1	10.0	9.7	9.5	9.3	9.7	9.9
Chem Creatinine mg/dL	0.6	1.3	1.2	1.3	1.3	1.0	1.2	1.1
Chem Glucose	70	110	86	87	94	86	87	83

TSH mIU/L	0.3	5.0	3.0					7.7

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Updated May 9, 2014, Page 2 of 7.

Looks best in a wide browser window. For treatments and some discussion, see Treatment Table. For charts of some values see Charts.

Test	Range Min	Range Max	2012 07/26	2012 08/23	2012 09/20	2012 10/17	2012 11/15	2012 12/13	2013 01/10	2013 02/07	2013 03/07	2013 04/04	2013 05/02	2013 05/30	2013 06/27	2013 07/25	2013 08/21	2013 09/19	2013 1017	2013 1113
Serum Lambda FLC mg/dL (neph)	0.57	2.63	2.30	2.72	2.61	2.38	2.92	3.25	2.56	3.09	2.84	3.30	2.89	3.72	2.61	3.10	2.93	2.92	3.06	3.35
Serum Kappa FLC mg/dL (neph)	0.33	1.94	1.27	1.11	1.14	1.40	1.61	1.70	1.61	1.78	1.46	1.80	1.94	2.00	1.95	1.67	2.00	1.07	1.31	1.26
Serum K/L Ratio (neph)	0.26	1.65	0.55	0.41	0.44	0.59	0.55	0.52	0.63	0.58	0.51	0.55	0.67	0.54	0.75	0.54	0.68	0.37	0.43	0.83
Serum IgG mg/dL	750	1550	1090	1180	1210	1180	1270	1250	1140	1140	1290	1230	1060	1070	1300	1290	1110	1130	1210	1300
Serum IgA mg/dL	80	450	35	37	33	33	86	65	53	48	49	50	44	40	54	45	40	44	43	41
Serum IgM mg/dL	45	300	14	16	16	14	20	24	18	16	16	21	17	17	22	19	14	19	17	17
Bone marrow plasma cells %	0.1	1.5
Abnormal cohort in marrow %		0
SPEP Monoclonal Peak g/dL		0	1.0	1.0	1.0	1.0	1.2	1.1	1.1	1.0	1.1	1.1	1.1	1.0	1.0	1.1	0.9	1.0	1.1	1.0
Total protein g/dL	6.3	7.9	7.1	7.3	7.3	7.1	7.8	6.9	7.4	6.8	6.8	7.5	7.1	7.0	7.0	7.3	6.8	7.1	7.3	7.0
Serum B2M mg/L	0.70	1.80
Serum ESR mm/hr	0	20

CBC RBC red blood count M/uL	4.32	5.72	4.05	4.09	4.22	4.35	4.13	4.31	4.41	4.19	4.26	4.53	4.40	4.33	4.38	4.23	4.44	4.41	4.44	4.39
CBC HGB hemoglobin g/dL	13.5	18.0	14.5	14.5	15.1	15.7	14.7	15.1	15.3	14.9	14.4	15.5	14.9	14.8	15.1	14.5	15.6	15.7	15.5	15.3
CBC PLT platelets K/uL	130	430	178	195	175	189	223	288	183	227	214	----	189	188	226	187	188	189	203	192
CBC WBC white blood count K/uL	3.5	10.8	4.9	4.3	3.7	4.4	5.5	4.4	4.1	4.2	4.7	5.2	4.5	4.8	5.1	4.9	4.2	4.3	4.6	4.4
CBC ANC absolute neutrophils K/uL	1.7	7.0	2.2	1.9	1.7	1.9	3.0	2.1	1.5	1.6	2.5	2.2	1.5	2.7	2.4	2.6	2.0	1.8	1.5	1.8
CBC EO# absolute eosinophils K/uL	0	0.35	0.2	0.3	0.0	0.2	0.2	0.4	0.1	0.2	0.1	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0.4	0.2

Chem LDH U/L	122	222	141	135	151	163	175	276	163	191	147	153	156	193	138	196	156	158	161	179
Chem ALT U/L	7.0	55.0	44	25	29	30	36	73	35	35	25	25	30	40	27	29	41	28	30	37
Chem AST U/L	15.0	48.0	27	26	25	28	31	85	31	39	23	26	27	35	25	34	35	25	26	26
Chem Albumin g/dL	3.4	5.0	3.9	3.9	4.0	4.0	4.0	3.5	3.9	3.9	3.7	3.9	3.9	3.7	3.8	4.1	3.7	3.8	3.9	3.7
Chem BUN mg/dL	7.0	18.0
Chem Calcium mg/dL	8.9	10.1	9.7	9.6	9.7	10.0	9.6	9.3	9.6	9.6	9.4	10.0	9.4	9.3	9.5	9.7	10.1	10.1	10.0	9.8
Chem Creatinine mg/dL	0.6	1.3	1.1	1.0	1.1	1.3	1.2	1.3	1.2	1.5	1.2	1.5	1.2	1.3	1.2	1.3	1.1	1.5	1.2	1.2
Chem Glucose	70	110	77	86	81	81	82	77	77	83	84	87	92	90	86	82	82	89	82	81

TSH mIU/L	0.3	5.0	3.8			4.7			6.2			9.8			6.0			4.0

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Updated May 9, 2014, Page 3 of 7.

Looks best in a wide browser window. For treatments and some discussion, see Treatment Table. For charts of some values see Charts.

Test	Range Min	Range Max	2011 03/09	2011 04/07	2011 05/05	2011 06/02	2011 06/30	2011 07/28	2011 08/25	2011 09/22	2011 10/19	2011 11/17	2011 12/14	2012 01/14	2012 02/07	2012 03/08	2012 04/04	2012 05/04	2012 05/29	2012 06/29
Serum Lambda FLC mg/dL (neph)	0.57	2.63	2.50	2.08	3.07	2.52	1.74	2.21	2.25	2.49	2.75	2.12	3.15	2.24	1.99	2.80	2.24	2.75	2.53	3.11
Serum Kappa FLC mg/dL (neph)	0.33	1.94	1.07	0.95	1.09	0.89	1.00	1.38	1.30	1.64	1.27	1.21	1.61	1.15	1.40	1.53	1.39	1.44	1.22	1.19
Serum K/L Ratio (neph)	0.26	1.65	0.43	0.46	0.36	0.35	0.57	0.62	0.58	0.66	0.46	0.57	0.51	0.51	0.70	0.55	0.62	0.52	0.48	0.38
Serum IgG mg/dL	750	1550	1050	1080	1130	1110	1070	1030	1150	1020	1310	1280	999	1190	1280	1100	1290	1210	1140	998
Serum IgA mg/dL	80	450	30	34	33	32	34	30	33	63	40	39	34	35	37	34	36	33	33	35
Serum IgM mg/dL	45	300	15	18	16	21	16	15	14	16	16	19	16	17	18	13	13	15	15	16
Bone marrow plasma cells %	0.1	1.5
Abnormal cohort in marrow %		0
SPEP Monoclonal Peak g/dL		0	1.0	1.0	1.0	1.1	1.0	1.0	1.1	1.0	1.1	1.1	1.1	1.2	1.1	1.0	1.1	1.1	1.1	1.0
Total Protein g/dL	6.3	7.9	6.8	6.9	6.8	7.3	7.2	7.2	7.3	7.1	7.2	7.3	7.0	7.4	7.4	7.3	7.1	7.2	7.4	7.1
Serum B2M mg/L	0.70	1.80
Serum ESR mm/hr	0	20

CBC RBC red blood count M/uL	4.32	5.72	4.40	4.27	4.11	4.13	4.28	4.17	4.08	4.09	4.07	4.18	4.17	4.36	4.18	3.86	4.08	4.31	4.37	4.15
CBC HGB hemoglobin g/dL	13.5	18.0	15.2	15.5	14.7	15.2	14.8	15.1	14.7	14.9	14.6	15.0	15.1	15.1	15.2	14.2	14.6	15.6	15.7	14.7
CBC PLT platelets K/uL	130	430	196	190	174	183	170	180	180	207	197	237	224	196	179	163	210	183	174	240
CBC WBC white blood count K/uL	3.5	10.8	5.3	4.9	4.6	4.9	3.6	5.1	3.8	6.2	4.8	5.3	4.8	4.8	4.5	3.7	6.1	5.3	4.6	4.9
CBC ANC absolute neutrophils K/uL	1.7	7.0	1.61	1.90	1.90	2.40	1.17	1.90	1.40	2.60	2.30	1.7	1.9	2.4	1.7	1.5	3.8	2.7	1.8	2.3
CBC EO# absolute eosinophils K/uL	0	0.35	0.35	0.20	0.30	0.20	0.37	0.30	0.20	0.50	0.20	0.20	0.20	0.4	0.4	0.2	0.2	0.2	0.2	0.2

Chem LDH U/L	122	222	158	145	173	157	150	162	159	164	156	150	159	146	124	163	135	132	138	198
Chem ALT U/L	7.0	55.0	34	31	38	31	35	38	38	54	51	39	38	37	33	56	24	39	30	45
Chem AST U/L	15.0	48.0	31	27	35	33	30	32	27	42	39	33	37	36	32	41	24	38	30	42
Chem Albumin g/dL	3.4	5.0	3.8	3.8	3.6	3.9	3.9	3.8	3.8	3.8	3.8	3.8	3.6	3.9	4.0	4.0	3.8	4.0	4.2	3.7
Chem BUN mg/dL	7.0	18.0
Chem Calcium mg/dL	8.9	10.1	9.6	9.9	9.4	10.4	10.0	9.8	10.5	10.0	10.0	10.3	10.3	10.0	10.2	10.3	9.6	10.0	9.7	10.2
Chem Creatinine mg/dL	0.6	1.3	1.0	1.2	1.1	1.2	1.3	1.3	1.1	0.9	1.1	1.1	1.1	1.0	1.0	1.0	1.2	1.0	1.2	1.0
Chem Glucose	70	110	82	82	75	84	82	86	85	84	83	87	82	84	89	87	86	86	84	84

TSH mIU/L	0.3	5.0	3.5			5.2			4.2			4.1			2.5			4.8

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Updated May 9, 2014, Page 4 of 7.

Test	Range Min	Range Max	2009 10/15	2009 11/12	2009 12/10	2010 01/07	2010 02/04	2010 03/04	2010 04/01	2010 04/29	2010 05/27	2010 06/29	2010 07/29	2010 08/24	2010 09/23	2010 10/20	2010 11/18	2010 12/16	2011 01/13	2011 02/07
Serum Lambda FLC mg/dL (neph)	0.57	2.63	2.68	2.61	2.36	2.18	2.78	2.10	1.82	2.41	2.58	1.74	1.86	2.79	2.58	2.78	2.92	2.41	2.49	2.47
Serum Kappa FLC mg/dL (neph)	0.33	1.94	0.91	1.07	0.99	0.76	0.87	1.06	0.27	1.11	1.31	1.01	1.01	1.45	1.10	1.21	1.08	1.10	1.27	1.26
Serum K/L Ratio (neph)	0.26	1.65	0.34	0.41	0.42	0.35	0.31	0.50	0.15	0.46	0.51	0.58	0.54	0.52	0.43	0.44	0.37	0.46	0.51	0.51
Serum IgG mg/dL	750	1550	1020	1100	1090	1110	1180	1130	1070	1010	1110	1120	1160	1100	1070	1130	1300	1080	1170	1200
Serum IgA mg/dL	80	450	20	26	21	20	27	27	24	21	23	26	26	29	31	26	46	37	38	33
Serum IgM mg/dL	45	300	14	15	14	14	14	14	15	14	15	16	12	18	19	19	25	18	19	19
Bone marrow plasma cells %	0.1	1.5
Abnormal cohort in marrow %		0
SPEP Monoclonal Peak g/dL		0	0.9	0.9	0.9	1.0	1.0	1.0	1.0	1.0	1.1	1.0	1.1	1.1	1.2	1.1	1.2	1.0	1.2	1.0
Serum B2M mg/L	0.70	1.80
Serum ESR mm/hr	0	20

CBC RBC red blood count M/uL	4.32	5.72	4.21	4.00	4.00	4.05	4.00	4.17	4.39	4.21	4.36	4.30	4.16	4.39	4.43	4.31	4.26	4.23	4.48	4.44
CBC HGB hemoglobin g/dL	13.5	18.0	15.0	14.4	14.3	14.4	14.2	14.7	14.6	14.1	14.7	14.5	14.0	15.7	15.8	14.9	15.0	14.6	15.3	16.0
CBC PLT platelets K/uL	130	430	185	188	175	186	181	170	175	168	178	200	172	199	210	166	230	202	174	171
CBC WBC white blood count K/uL	3.5	10.8	4.2	3.9	3.7	3.5	3.8	3.4	3.3	3.3	3.6	3.4	2.8	4.4	4.2	4.3	5.9	5.1	3.3	4.1
CBC ANC absolute neutrophils K/uL	1.7	7.0	1.78	1.53	1.55	1.38	1.22	1.29	0.94	0.73	0.92	1.09	0.93	1.41	1.60	2.14	2.30	2.50	1.19	1.40
CBC EO# absolute eosinophils K/uL	0	0.35	0	0	0	0	0.30	0	0.37	0.40	0.39	0.17	0.20	0.30	0.50	0.37	0.10	0.10	0.43	0.30

Chem LDH U/L	122	222	154	146	144	145	159	157	149	147	157	156	138	134	146	167	137	139	143	119
Chem ALT U/L	7.0	55.0	33	35	34	41	38	41	112	44	34	36	37	38	38	42	35	30	32	32
Chem AST U/L	15.0	48.0	26	31	29	32	38	29	85	37	31	31	34	33	34	37	33	33	30	27
Chem Albumin g/dL	3.4	5.0	3.7		3.7	3.6	3.7	3.8	3.7	3.9	4.0	4.0	3.9	4.0	3.8	3.9	3.8	3.7	3.9	3.7
Chem BUN mg/dL	7.0	18.0
Chem Calcium mg/dL	8.5	10.3	10.3	9.8	10.0	9.6	9.8	10.1	9.8	9.7	9.9	9.9	9.9	10.1	10.0	10.0	10.3	9.8	10.3	10.1
Chem Creatinine mg/dL	0.6	1.3	1.0	1.0	1.1	1.1	1.1	1.0	1.2	1.3	1.3	1.2	1.0	1.3	0.9	1.0	0.9	1.0	1.4	1.0
Chem Glucose	70	110	79	79	79	80	87	74	82	87	90	95	90	83	88	89	89	79	85	90

TSH mIU/L	0.3	5.0	4.4			3.7			3.1			2.3			2.7			2.2

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Page 5 of 7

Test	Range Min	Range Max	2008 05/29	2008 06/26	2008 07/24	2008 08/22	2008 09/16	2008 10/16	2008 11/13	2008 12/11	2009 01/08	2009 02/05	2009 03/04	2009 04/02	2009 04/30	2009 05/28	2009 06/25	2009 07/23	2009 08/20	2009 09/17
Serum Lambda FLC mg/dL (neph)	0.57	2.63	4.25	4.03	3.30	3.57	2.64	3.14	3.25	4.03	3.31	2.78	2.64	3.04	2.55	2.60	2.63	1.95	2.07	2.54
Serum Kappa FLC mg/dL (neph)	0.33	1.94	1.07	0.88	0.97	1.02	0.91	1.16	1.19	1.84	1.32	1.05	1.10	1.14	0.91	1.01	0.96	0.95	0.96	1.09
Serum K/L Ratio (neph)	0.26	1.65	0.25	0.22	0.29	0.29	0.34	0.37	0.37	0.46	0.40	0.38	0.42	0.38	0.36	0.39	0.36	0.49	0.46	0.43
Serum IgG mg/dL	750	1550	1260	1450	1360	1040	1180	1130	1170	1260	1350	1160	923	1060	1060	1030	1010	1010	979	1070
Serum IgA mg/dL	80	450	13	13	12	12	13	15	15	45	25	17	16	18	16	19	26	26	23	25
Serum IgM mg/dL	45	300	15	14	14	12	13	14	20	23	16	16	12	14	12	13	16	19	14	15
Bone marrow plasma cells %	0.1	1.5
Abnormal cohort in marrow %		0
SPEP Monoclonal Peak g/dL		0	1.2	1.1	1.1	1.0	1.0	0.9	1.0	1.0	1.1	1.0	0.9	0.9	0.8	0.9	0.9	0.8	0.8	0.9
Urine Kappa light chains mg/dL		1.5
Urine Lambda light chains mg/dL		2.0
Serum B2M mg/L	0.70	1.80
Serum ESR mm/hr	0	20

CBC RBC red blood count M/uL	4.32	5.72	4.23	4.28	4.17	3.99	3.90	3.97	4.19	4.20	4.36	4.28	3.89	4.26	4.01	4.06	3.93	4.13	4.01	4.08
CBC HGB hemoglobin g/dL	13.5	18.0	14.5	14.8	14.3	13.8	13.6	13.8	14.6	14.6	15.3	14.9	13.7	14.7	14.3	14.4	14.0	14.8	14.5	14.7
CBC PLT platelets K/uL	130	430	235	222	239	212	218	219	224	248	210	213	199	214	189	192	221	196	167	193
CBC WBC white blood count K/uL	3.5	10.8	6.0	5.5	4.7	4.4	5.3	4.4	4.3	5.3	4.6	5.0	4.5	4.2	3.6	4.0	5.6	3.9	3.7	4.1
CBC ANC absolute neutrophils K/uL	1.7	7.0	2.41	1.65	2.09	1.84	2.65	1.95	1.59	2.65	2.11	2.21	1.83	1.93	1.50	1.82	2.99	1.65	1.45	1.56
CBC EO# absolute eosinophils K/uL	0	0.35	0.53	0.66	0	0.25	0	0	0.47	0	0.23	0	0	0	0	0	0	0.01	0	0.53

Chem LDH U/L	140	271	139	162	136							162	135	144	143	130	168	133	168	144
Chem ALT U/L	7.0	55.0	37	40	29	36	30	40	32	87	46	40	44	40	60	35	50	35	46	39
Chem AST U/L	15.0	48.0	25	27	23	29	25	27	24	69	41	33	32	26	35	23	30	27	35	28
Chem Albumin g/dL	3.4	5.0	3.2		4.2	3.4	3.4	3.4	3.4	3.6	3.7	3.7	3.2	3.5	3.5	3.4	3.3	3.4	3.5	3.5
Chem BUN mg/dL	7.0	18.0
Chem Calcium mg/dL	8.5	10.3	9.7	10.1	9.7	9.3	9.7	9.6	9.8	10.1	9.9	9.7	9.7	9.5	9.6	10.0	9.6	9.7	10.0	9.9
Chem Creatinine mg/dL	0.6	1.3	1.1	1.0	1.0	1.3	1.0	1.1	0.9	1.0	1.1	1.0	1.0	1.0	0.9	1.0	1.0	1.1	1.0	1.1
Chem Glucose	70	110	82	87	94	83	89	83	83	73	88	84	91	87	84	86	80	80	78	88

TSH mIU/L	0.3	5.0		5.4								5.4			2.0			4.0

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Page 6 of 7

Test	Range Min	Range Max	2006 2/24	2006 6/02	2006 6/26	2006 9/01	2006 12/04	2007 1/11	2007 2/22	2007 3/08	2007 3/28	2007 4/26	2007 6/27	2007 8/02	2007 9/06	2007 10/17	2007 12/26	2008 03/07	2008 04/03	2008 05/01
Serum Lambda FLC mg/dL (neph)	0.57	2.63	3.79	2.35	4.10	4.57		4.46	4.79		4.34	3.71	4.17		3.65	3.63	4.67	5.88	5.70	4.41
Serum Kappa FLC mg/dL (neph)	0.33	1.94	0.17	1.32	0.17	0.20		0.97	0.70		0.72	0.59	0.03		0.17	0.17	0.18	0.14	0.98	0.75
Serum K/L Ratio (neph)	0.26	1.65	0.05	0.56	0.04	0.04		0.22	0.15		0.16	0.16	0.01		0.05	0.05	0.04	0.02	0.17	0.17
Serum Lambda LC mg/dL (ifix)	325	725					3310	3250	2710		3010	2970	3350		3530	3130	3720
Serum Kappa LC mg/dL (ifix)	625	1350					78	72	73		72	72	74		69	62	68
Serum K/L Ratio (ifix)	1.47	2.95					0.02	0.02	0.03		0.02	0.02	0.02		0.02	0.02	0.02
Serum IgG mg/dL	750	1550	1593	1881	2100	1936	2050	2200	2320		2430	2560	2730		3110	2690	3000	2960	2230	1610
Serum IgA mg/dL	80	450	27	20		20	22	22	23		20	19	19		19	16	16	15	12	13
Serum IgM mg/dL	45	300	12	21		20	23	21	19		23	22	22		20	19	19	15	16	13
Bone marrow plasma cells %	0.1	1.5								6.8%								5-10%
Abnormal cohort in marrow %		0								4.0
SPEP Monoclonal Peak g/dL		0	1.2	1.4		1.2	1.57	1.75	1.32		1.70	1.75	1.96		1.90	1.85	2.05	2.70	1.90	1.40
Urine Kappa light chains mg/dL		1.5	0.0	29.1	0.0	0.0	0.0		1.6		0.0		0.0		0.0	0.0	0.0
Urine Lambda light chains mg/dL		2.0	0.0	469.0	0.0	0.0	0.0		0.0		0.0		0.4		0.0	0.0	0.57
Serum B2M mg/L	0.70	1.80	1.51	1.58	1.55	1.57	1.72		1.98		2.03	2.04						1.89
Serum ESR mm/hr	0	20			10			13	21		10	15				15	27

CBC RBC red blood count M/uL	4.50	5.70	4.70	4.96		4.49	4.61	4.67	4.66	4.42	4.55	4.60			4.56	4.24	4.44	4.62	4.42	3.95
CBC HGB hemoglobin g/dL	13.5	18.0	14.9	16.0		14.9	15.1	15.6	15.0	14.2	14.9	15.1			15.1	13.9	14.4	15.4	15.1	13.5
CBC PLT platelets K/uL	130	430	170	190		164	193	227	234	200	184	193			185	180	188	211	303	243
CBC WBC white blood count K/uL	3.5	10.8	4.2	5.1		3.7	4.4	4.9	4.7	5.0	4.3	4.4			5.6	4.2	3.9	5.6	7.7	6.0
CBC EO# absolute eosinophils K/uL	0	0.5	0.3	0.3		0.4		0.4	0.4		0.5	0.4			0.3	0.3	0.2	0.17	0.17	0

Chem LDH U/L	140	271	173	252		324	183	189	233		183	202	190		182	226	188	186	158	131
Chem ALT U/L	7.0	52.0		36		28	25	26	33		22	24	27	22	27	35	20	45	44	32
Chem AST U/L	15.0	37.0		38		33	30	29	38		25	31	28	31	29	41	30	38	32	23
Chem Albumin g/dL	3.4	5.0	4.1	4.5		4.3	4.5	4.3	3.9		4.0	4.5	4.3	4.3	4.4	4.1	4.2	4.5	3.4	3.2
Chem BUN mg/dL	7.0	18.0		23		22	21	24	18		20	21	26	17	22	18	15
Chem Calcium mg/dL	8.5	10.3		9.7		9.3	9.5	9.2	9.9		9.4	10.2	10.0	10.2	10.4	9.7	10.0	10.2	9.9	9.6
Chem Creatinine mg/dL	0.6	1.3		1.1		1.1	1.3	1.1	1.1		1.1	1.1	1.1	1.1	1.2	1.0	1.0	0.9	1.0	1.1
Chem Glucose	70	110		65		61	94	63	73		65	56	97	97	118	80	68	91	89	88

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5

Myeloma Test Results, Page 7 of 7

Test	Range Min	Range Max	2003 4/01	2003 7/02	2003 8/01	2003 8/07	2003 10/09	2003 12/12	2004 1/12	2004 2/16	2004 4/06	2004 5/06	2004 6/08	2004 8/10	2004 11/05	2005 2/07	2005 5/10	2005 8/10	2005 8/19	2005 11/23
Serum Lambda FLC mg/dL (neph)	0.57	2.63					5.21	6.41	4.47	3.88	2.99		4.40	4.07	3.07	3.20	3.27			3.26
Serum Kappa FLC mg/dL (neph)	0.33	1.94					0.13	0.21	0.77	0.90	0.24		0.20	0.17	0.03	0.03	0.16			0.20
Serum K/L Ratio (neph)	0.26	1.65					0.02	0.03	0.17	0.23	0.08		0.04	0.04	0.01	0.01	0.05			0.06
Serum Lambda LC mg/dL (ifix)	325	725		1930
Serum Kappa LC mg/dL (ifix)	625	1360		101
Serum Kappa/Lambda Ratio (ifix)	1.47	2.95		0.05
Serum IgG mg/dL	700	1700		1260			1277	1302	1437				1305		1508		1706	1715		1511
Serum IgA mg/dL	65	400		21			75	68					80		24	24	34	25		23
Serum IgM mg/dL	60	280		17			< 25	< 25					28		21	26	14	28		20
Bone marrow plasma cells %	0.1	1.5			9.8														8.2
Abnormal cohort in marrow %		0			<1.0														2.0
SPEP Monoclonal Peak g/dL		0		0.52														1.1		1.1
Urine light chains mg/dL				0			0		0	0	0		0	0	0	0	0	0		0
Serum B2M mg/L	0.70	1.80				1.45		1.46									1.48	1.86

CBC RBC red blood count M/uL	4.50	5.70		4.64	4.50	4.48	4.53		4.60	4.66	4.60		4.48	4.58	4.76	4.78	4.77	4.78	4.56	4.53
CBC HGB hemoglobin g/dL	13.5	18.0		15.3	14.6	14.5	14.7		15.0	15.5	14.9		14.4	14.9	15.4	15.6	15.6	15.5	14.9	14.7
CBC PLT platelets K/uL	130	430		189	178	176	181		203	205	187		182	175	165	172	184	166	174	172
CBC WBC white blood count K/uL	3.5	10.8		9.4	5.0	5.0	4.3		4.9	4.7	3.5		9.6	9.3	3.7	5.4	4.6	5.6	5.1	4.4
CBC EO# absolute eosinophils K/uL	0	0.5				0.4	0.3		0.5	0.6	0.3		0.2	0.1	0.4	0.4

Chem LDH U/L	100	190				168	167		134	171	152		171	194		166	184	192		192
Chem ALT U/L	30.0	65.0				66.0		67.0	52.0	70.0	73.0		57.0	51.0	43	53	51	58		44
Chem AST U/L	15.0	37.0				46.0		43.0	27.0	40.0	29.0		37.0	34.0	27	35	30	37		35
Chem Albumin g/dL	3.4	5.0		4.5		4.2		4.4	4.2	4.3	4.1		4.4	4.3	4.5	4.5	4.6	4.3		4.3
Chem BUN mg/dL	5.0	25.0	20.0			26.0		17.0	26.0			27.0		27.0	21		19	20		25
Chem Calcium mg/dL	8.5	10.3		9.8		9.3		9.4	9.3					9.9	9.3		9.7	9.1		9.0
Chem Creatinine mg/dL	0.6	1.3	1.1			1.2		1.0	1.1			1.1		1.3	1.1		1.1	1.2		1.2
Chem Glucose	70	110				90		90	76					109	45		97	86		78

MGUS:	SPEP spike present but less than 3 mg/dL, and	Int’l myeloma staging system:	Stage I	B2M < 3.5 & albumin => 3.5
	Bone marrow plasma cells less than 10%, and		Stage II	B2M < 3.5 & albumin < 3.5; or 5.5 > B2M => 3.5
	No myeloma-related organ, tissue, or bone impairment		Stage III	B2M => 5.5